Compositions comprising a biological control agent and an insecticide 机翻标题: 暂无翻译,请尝试点击翻译按钮。

公开号/公开日
AU2013269663 A1 2014-12-04 [AU2013269663]AU2013269663 B2 2016-12-01 [AU2013269663] / 2014-12-042016-12-01
申请号/申请日
2013AU-0269663 / 2013-05-29
发明人
HELLWEGE ELKE;ANDERSCH WOLFRAM;STENZEL KLAUS;SPRINGER BERND;
申请人
BAYER CROPSCIENCE;
主分类号
IPC分类号
A01N-041/10A01N-043/56A01N-063/00A01P-003/00
摘要
(AU2013269663) The present invention relates to a composition comprising at least one biological control agent selected from the group consisting of Bacillus chitinosporus AQ746 (NRRL Accession No.  B-21618), Bacillus mycoldes AQ726 (NRRL Accession No.  B-21664), Bacillus pumilus (NRRL Accession No.  B-30087), Bacillus pumilus AQ717 (NRRL Accession No.  B-21662), Bacillus sp.  AQ175 (ATCC Accession No. 55608), Bacillus sp, AQ177 (ATCC Accession No. 55609), Bacillus sp.  AQ178 (ATCC Accession No. 53522), Bacillus subtilis AQ743 (NRRL Accession No.  B-21665), Bacillus subtilis AQ713 (NRRL Accession No.  B-21661 ), Bacillus subtilis AQ153 (ATCC Accession No. 55614), Bacillus thuringiensis BD#32 (NRRL Accession No.  B-21530), Bacillus thuringiensis AQ52 (NRRL Accession No.  B-21619), Muscodor albus 620 (NRRL Accession No. 30547), Muscodor roseus A3-5 (NRRL Accession No. 30548), Rhodococcus globerulus AQ719 (NRRL Accession No.  B- 21663), Streptomyces galbus (NRRL Accession No. 30232), Streptomyces sp. (NRRL Accession No.  B-30145), Bacillus thuringiensis subspec. kurstaki BMP 123, Bacillus subtilis AQ30002 (NRRL Accession No.  B-50421), and Bacillus subtilis AQ 30004 (NRRL Accession No.  B-50455) and/or a mutant of these strains having all the identifying characteristics of the respective strain, and/or a metabolite produced by the respective strain that exhibits activity against insects, mites, nematodes and/or phytopathogens and at least one insecticide selected from the group consisting of ryanodine receptor modulators in a synergistically effective amount.  Furthermore, the present invention relates to the use of this composition as well as a method for reducing overall damage of plants and plant parts.
机翻摘要
暂无翻译结果,您可以尝试点击头部的翻译按钮。
地址
代理人
代理机构
;
优先权号
2012EP-0169936 2012-05-30 2012EP-0197137 2012-12-14 2013WO-EP61036 2013-05-29
主权利要求
(AU2013269663) 1. A composition comprising at least one biological control agent selected from the group consisting of Bacillus chitinosporus AQ746 (NRRL Accession No. B-21618), Bacillus mycoides AQ726 (NRRL Accession No. B-21664), Bacillus pumilus (NRRL Accession No. B-30087), Bacillus pumilus AQ717 (NRRL Accession No. B-21662), Bacillus sp. AQ175 (ATCC Accession No. 55608), Bacillus sp. AQ177 (ATCC Accession No. 55609), Bacillus sp. AQ178 (ATCC Accession No. 53522), Bacillus subtilis AQ743 (NRRL Accession No. B-21665), Bacillus subtilis AQ713 (NRRL Accession No. B-21661), Bacillus subtilis AQ153 (ATCC Accession No. 55614), Bacillus thuringiensis BD#32 (NRRL Accession No. B-21530), Bacillus thuringiensis AQ52 (NRRL Accession No. B-21619), Muscodor albus 620 (NRRL Accession No. 30547), Muscodor roseus A3-5 (NRRL Accession No. 30548), Rhodococcus globerulus AQ719 (NRRL Accession No. B-21663), Streptomyces gaibus (NRRL Accession No. 30232), Streptomyces sp. (NRRL Accession No. B-30145), Bacillus thuringiensis subspec. kurstaki BMP 123, Bacillus subtilis AQ30002 (NRRL Accession No. B-50421), and Bacillus subtilis AQ 30004 (NRRL Accession No. B-50455), and/or a mutant of these strains having all the identifying characteristics of the respective strain, and/or a metabolite produced by the respective strain that exhibits activity against insects, mites, nematodes and/or phytopathogens and at least one insecticide selected from the group consisting of ryanodine receptor modulators In a synergistically effective amount. 2. The composition according to claim 1, wherein the ryanodine receptor modulator is selected from the group consisting of diamides. 3. The composition according to claim 2, wherein the ryanodine receptor modulator is selected from the group consisting of Chlorantraniliprole, Cyantraniliprote, and Flubendiamide. 4. The composition according to any one of claims 1 to 3, further comprising at least one fungicide, with the proviso that the biological control agent and the fungicide are not identical.  5. The composition according to any one of claims 1 to 4, wherein the fungicide Is selected from the group consisting of inhibitors of the ergosterol biosynthesis, inhibitors of the respiratory chain at complex I or II, inhibitors of the respiratory chain at complex III, inhibitors of the mitosis and cell division, compounds capable to induce a host defense, inhibitors of the amino acid and/or protein biosynthesis, inhibitors of the ATP production, inhibitors of the cell wall synthesis, inhibitors of the lipid and membrane synthesis, inhibitors of the melanine biosynthesis, inhibitors of the nucleic acid synthesis, inhibitors of the signal transduction, compounds capable to act as an uncoupler such as binapacryl, dinocap, ferimzone, fluazinam, meptyldinocap and further compounds, like for example benthiazole, bethoxazin, capsimycin, carvone, chinomethionat, pyriofenone (chlazafenone), cufraneb, cyflufenamid, cymoxanil, cyprosulfamide, dazomet, debacarb, dichlorophen, diclomezine, difenzoquat, difenzoquat methylsuiphate, diphenylamine, ecomate, fenpyrazamine, flumetover, fluoroimide, flusulfamide, flutianil, fosetyl-aluminium, fosetyl-calcium, fosetyl-sodium, hexachlorobenzene, irumamycin, methasulfocarb, methyl isothiocyanate, metrafenone, mildlomycin, natamycin, nickel dimethyldithiocarbamate, nitrothalisopropyl, octhilinone, oxamocarb, oxyfenthiin, pentachlorophenol and salts, phenothrin, phosphorous acid and its salts, propamocarb-fosetylate, propanosinesodium, proquinazid, pyrimorph, (2E)-3-(4-tert-butylpheny1)-3-(2-chloropyridin-4-y1)-1-(morpholin-4-yl)prop-2-en-1-one, (2Z)-3-(4-tert-butylpheny1)-3-(2-chloropyridin-4-y1)- 1-(morpholin-4-yl)prop-2-en- 1 -one, pyrrolnitrine, tebufloquin, tecloffalam, tolnifanide, triazoxide, trichlamide, zarilamid, (3S,6S,7R,8R)-8-benzy1-34({3-[(isobutyryloxy)methoxy]-4-methoxypyridin-2-yllcarbonyl)amino]-6-methy1-4,9-dioxo-1,5-dioxonan-7-y1 2-methylpropanoate, 1-(4-{4-[(5R)-5-(2,6-difluoropheny1)-4,5-dihydro-1,2-oxazol-3-y1]-1,3-thiazol-2-yllpiperidin-1-y1)-2[5-methy1-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, 1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-y1]-1,3-thiazol-2-yllpiperidin-1-y1)-215-methy1-3-(trifluoromethyl)-1H-pyrazol-1-yllethanone, 1-(4-{445-(2,6-difluoropheny1)-4,5-dihydro-1,2-oxazol-3-y1]-1,3-thiazol-2-yllpiperidin-1-y1)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, 1-(4-methoxyphenoxy)-3,3-dimethylbutan-2-yi 1 Himidazole1-carboxylate, 2,3,5,6-tetrachloro-4-(methylsulfonyl)pyridine, 2,3-dibuty1-6-chlorothieno[2,3-d]pyrimidin-4(3H)-one, 2,6-dimethy1-1H,51-141,4]dithilno[2, 3-c :5,6-cldipyrrole-1,3,5,7(2H,6H)-tetrone, 245-methy1-3-(trifluoromethyl)-1H-pyrazol-1-y1]-1-(4-{4-[(5R)-5-pheny1-4,5-dihydro-1,2-oxazol-3-y1]-1,3-thiazol-2-yllpiperldin-1-yl)ethanone, 245-methy1-3-(trifluoromethyl)-1H-pyrazol-1-y1]-1-(4-{4-[(5S)-5-pheny1-4,5-dihydro-1,2-oxazol-3- y1]-1,3-thiazol-2-yllpiperidin-1-y1)etha none, 2-[5-methy1-3-(trifluoromethyl)-1H-pyrazol-1-y1]-1-{4-[4-(5-pheny1-4,5-dihydro-1,2-oxazol-3-0)-1,3-thiazol-2-yl]piperidin-1-yllethanone, 2-butoxy-6-lodo-3-propyl-4H-chromen-4-one, 2-chloro-5-[2-chloro-1-(2,6-dIfluoro-4-methoxypheny1)-4-methyl-1H-imidazol-5-yl]pyridine, 2-phenylphenol and salts, 3-(4,4,5-trifluor0-3,3-dimethy1-3,4-dihydroisoquinolin-1-y1)quinolone, 3,4,5-trichloropyridine-2,6-dicarbonitrile, 345-(4-chloropheny1)-2,3-dimethy1-1,2-oxazolidin-3-yl]pyridine, 3-chloro-5-(4-chloropheny1)-4-(2,6-difluoropheny1)-6-methylpyridazine, 4-(4-chloropheny1)-5-(2,6-difluoropheny1)-3,6-dimethylpyridazine, 5-amino-1,3,4-thiadiazole-2-thiol, 5-chloro-N'-phenyi-N'-(prop-2-yn-1-yl)thiophene-2-sulfonohydrazIde, 5-fluoro-2-[(4-fluorobenzy1)oxy]pyrImidin-4-amine, 5-fluoro-2-[(4-methylbenzyfloxy]pyrimidin-4-amine, 5-methyI-6-octy1[1,2,4]triazolo[1,5-a]pyrimidin-7-amine, ethyl (2Z)-3-amino-2-cyano-3-phenylprop-2-enoate, N'-(4-{[3-(4-chlorobenzy1)-1,2,4-thiadiazol-5-yl]oxy}-2,5-dimethy1pheny1)-N-ethy1-N-methylimidoformamIde, N-(4-c hlorobenzy1)-343-methoxy-4-(prop-2-yn-1-yloxy)phenyllpropanamide, N-[(4-chlorophenyl)(cyano)methyl]-343-methoxy-4-(prop-2-yn-1-yloxy)phenyl]propanamide, N-[(5-bromo-3-chloropyridin-2-yl)methyI]-2,4-dichloropyridine-3-carboxamide, N-[1-(5-bromo-3-chloropyridin-2-yflethyl]-2,4-dichloropyridine-3-carboxamide, N-E1-(5-bromo-3-chloropyridln-2-y1)ethy11-2-fluoro-4-loclopyridine-3-carboxamide, N-{(E)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2, 3-difluorophenyl]methyll-2-phenylacetamide, N-{(Z)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methy11-2-pheny1acetamide, N'-{4-[(3-tert-buty1-4-cyano-1,2-thiazol-5-yl)oxy]-2-chloro-5-methylphenyll-N-ethy1-N-methylimidoformamide, N-methy1-2-(1-{[5-methy1-3-(trifluoromethy1)-1H-pyrazol-1-yl]acetyllpiperidin-4-y1)-N- (1,2,3,4-tetrahydronaphthalen-1-y1)-1,3-thiazole-4-carboxamide, N-methy1-2-(1-{[5-methy1-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyllpiperidin-4-y1)-N-[(1R)-1,2,3,4- tetrahydronaphthalen-1-y1]-1,3-thiazole-4-carboxamIde, N-methy1-2-(1-{[5-methy1-3-(trifluoromethyl)-1H-pyrazol-1-Aacetyllpiperidin-4-y1)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-y1]-1,3-thiazole-4-carboxamide, penty1 {6-[({[(1-methy1-1H-tetrazol-5-y1)(phenyOmethyfldenelaminoloxy)methyllpyridin-2-yllcarbamate, phenazine1-carboxylic acid, quinolin-8-ol, quinolin-8-ol sulfate (2:1), tert-butyl {6-[({[(1-methy1-1H-tetrazol-5-y1)(phenyl)methylenelaminoloxy)methyl]pyridin-2-yllcarbamate, 1-methyl-3-(trifluoromethyl)-N-[2'-(trifluoromethyl)bipheny1-2-0]-1H-pyrazole-4-carboxamide, N(4'chlorobipheny1-2-y1)-3-(dIfluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, N(2',4'dichlorobipheny1-2-y1)-3-(difluoromethyl)-1-methy1-1H-pyrazole-4-carboxamide, 3-(difluoromethyl)-1-methyl-N-[4'-(trifluoromethy1)biphenyl-2-y1]-1H-pyrazole-4- carboxamide, N-(2',51-difluorobipheny1-2-y1)-1-methy1-3-(trifluoromethyl)-1H-pyrazole-4- carboxamide, 3-(difluoromethyl)-1-methyl-N444prop-1-yn-1-y1)biphenyl-2-y1]-1H-pyrazole-4-carboxamide, 5-fluoro-1,3-dimethyl-N-[4'-(prop-1-yn-l-y1)biphenyl-2-y1]-1H-pyrazole-4-carboxamide, 2-chloro-N-[4'-(prop-1-yn-l-y1)biphenyl-2-yl]pyridine-3-carboxamide, 3-(difluoromethyl)-N44'-(3,3-dimethylbut-l-yn-l-y1)biphenyl-2-y1]-1-methyl-1H-pyrazole-4-carboxamide, N44'-(3,3-dimethylbut-l-yn-l-y1)biphenyl-2-y11-5-fluoro-1,3-dimethy1-1H-pyrazole-4-carboxamide, 3-(difluoromethyl)-N-(4'-ethynylbipheny1-2-y1)-1-methyl-1H-pyrazole-4-carboxamide, N-(4'-ethynylbipheny1-2-y1)-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide, 2-chloro-N-(4'-ethynylbipheny1-2-yl)pyridine-3-carboxamide, 2-chloro-N-[4'-(3,3-dimethylbut-1-yn-l-yl)biphenyl-2-Apyridine-3-carboxamide, 4-(difluoromethyl)-2-methyl-N-[41-(trifluoromethyl)bipheny1-2-A-1,3-thiazole-5-carboxamide, 5-fluoro-N14'-(3-hydroxy-3-methylbut-1-yn-1-Abipheny1-2-y11-1,3-dimethyl-1H-pyrazole-4-carboxamide, 2-chloro-N-[4'-(3-hydroxy-3-methylbut-l-yn-l-y1)biphenyl-2-yl]pyridine-3-carboxamide, 3-(difluoromethyl)-N-[443-methoxy-3-methylbut-l-yn-1-y1)biphenyl-2-y1]-1-methy1-1H-pyrazole-4-carboxamide, 5-fluoro-N-[4'-(3-methoxy-3-methylbut-1-yn-l-yl)bipheny1-2-y1]-1,3-dimethyl-1H-pyrazole-4-carboxamide, 2-chloro-N-[4'-(3-methoxy-3-methylbut-1-yn-l-y1)biphenyl-2-yl]pyridine-3-carboxamide, (5-bromo-2-methoxy-4-methylpyridin-3-y1)(2,3,4-trimethoxy-6-methylphenyl)methanone, N-[2-(4-{[3-(4-chlorophenyl)prop-2-yn-1-yl]oxy}-3-methoxyphenyl)ethyli-N2-(methylsulfonyl)valinamide 4-oxo-4-[(2-phenylethyl)amino]butanoic acid, but-3-yn-l-y1 {6-[({[(Z)-(1-methy1-1H-tetrazol-5-y1)(phenyl)methylenejaminoloxy)methyllpyridin-2-yllcarbamate, 4-Amino-5-fluorpyrimidin-2-ol, propyl 3,4,5-trihydroxybenzoate and oryzastrobin.  6. The composition according to any one of claims 1 to 5, wherein the biological control agent is selected from the group consisting of Bacillus pumilus (NRRL Accession No. B-30087), Bacillus subtffis AQ30002 (NRRL Accession No. B-50421), and Bacillus subtilis AQ713 (NRRL Accession No. B-21661) and/or a mutant of these stains having all the identifying characteristics of the respective strain, and/or a metabolite produced by the respective strain that exhibits activity against insects, mites, nematodes and/or phytopathogens. 7. The composition according to any one of claims 1 to 6 additionally comprising at least one auxiliary selected from the group consisting of extenders, solvents, spontaneity promoters, carriers, emulsifiers, dispersants, frost protectants, thickeners and adjuvants. 8. A seed treated with the composition according to any one of claims 1 to 7. 9. A seed according to claim 8, wherein the insecticide in the composition is Cyantraniliprole. 10. A use of the composition according to any one of claims 1 to 7 as Insecticide and/or fungicide. 11. The use according to claim 10 for reducing overall damage of plants and plant parts as well as losses in harvested fruits or vegetables caused by insects, mites, nematodes and/or phytopathogens. 12. The use according to claim 10 or 11 for treating conventional or transgenic plants or seed thereof. 13. A method for reducing overall damage of plants and plant parts as well as losses in harvested fruits or vegetables caused by insects, mites, nematodes and/or phytopathogens comprising the step of simultaneously or sequentially applying at least one biological control agent selected from the group consisting of Bacillus chitinosporus AQ746 (NRRL Accession No. B-21618), Bacillus mycoides AQ726 (NRRL Accession No. B-21664), Bacillus pumilus (NRRL Accession No. B-30087), Bacillus pumilus AQ717 (NRRL Accession No. B-21662), Bacillus sp. AQ175 (ATCC Accession No. 55608), Bacillus sp. AQ177 (ATCC Accession No. 55609), Bacillus sp. AQ178 (ATCC Accession No. 53522), Bacillus subtfils AQ743 (NRRL Accession No. B-21665), Bacillus subtilis AQ713 (NRRL Accession No. B-21661), Bacillus subtilis AQ153 (ATCC Accession No. 55614), Bacillus thuringiensis BD#32 (NRRL Accession No. B-21530), Bacillus thuringlensis AQ52 (NRRL Accession No. B-21619), Muscodor albus 620 (NRRL Accession No. 30547), Muscodor roseus A3-5 (NRRL Accession No. 30548), Rhodococcus globerulus AQ719 (NRRL Accession No. B-21663), Streptomyces galbus (NRRL Accession No. 30232), Streptomyces sp. (NRRL Accession No. B-30145), Bacillus thuringlensis subspec. kurstaki BMP 123, Bacillus subtilis AQ30002 (NRRL Accession No. B-50421), and Bacillus subtilis AQ 30004 (NRRL Accession No. B-50455), and/or a mutant of these stains having all the identifying characteristics of the respective strain, and/or a metabolite produced by the respective strain that exhibits activity against insects, mites, nematodes and/or phytopathogens and at least one insecticide selected from the group consisting of ryanodine receptor modulators, and optionally at least one fungicide on the plant, plant parts, harvested fruits, vegetables and/or plants locus of growth in a synergistically effective amount, with the proviso that the biological control agent and optional fungicide are not identical. 14. The method according to claim 13, wherein the ryanodine receptor modulator is selected from the group consisting of diamides. 15. Kit-of-parts comprising at least one biological control agent selected from the group consisting of Bacillus chitinosporus AQ746 (NRRL Accession No. B-21618), Bacillus mycoides AQ726 (NRRL Accession No. B-21664), Bacillus pumilus (NRRL Accession No. B-30087), Bacillus pumilus AQ717 (NRRL Accession No. B-21662), Bacillus sp. AQ175 (ATCC Accession No. 55608), Bacillus sp. AQ177 (ATCC Accession No. 55609), Bacillus sp. AQ178 (ATCC Accession No. 53522), Bacillus subtilis AQ743 (NRRL Accession No. B-21665), Bacillus subtilis AQ713 (NRRL Accession No. B-21661), Bacillus subtilis AQ153 (ATCC Accession No. 55614), Bacillus thuringlensis BD#32 (NRRL Accession No. B-21530), Bacillus thuringlensis AQ52 (NRRL Accession No. B-21619), Muscodor albus 620 (NRRL Accession No. 30547), Muscodor roseus A3-5 (NRRL Accession No. 30548), Rhodococcus globerulus AQ719 (NRRL Accession No. B-21663), Streptomyces gaibus (NRRL Accession No. 30232), Streptomyces sp. (NRRL Accession No. B-30145), Bacillus thuringlensis subspec. kurstaki BMP 123, Bacillus subtilis AQ30002 (NRRL Accession No. B-50421), and Bacillus subtilis AQ 30004 (NRRL Accession No. B-50455), and/or a mutant of these stains having all the identifying characteristics of the respective strain, and/or a metabolite produced by the respective strain that exhibits activity against insects, mites, nematodes and/or phytopathogens, and at least one insecticide selected from the group consisting of ryanodine receptor modulators, in a synergistically effective amount in a spatially separated arrangement.
法律状态
(AU2013269663) LEGAL DETAILS FOR AU2013269663  Actual or expected expiration date=2033-05-29    Legal state=ALIVE    Status=GRANTED     Event publication date=2013-05-29  Event code=AU/APP  Event indicator=Pos  Event type=Examination events  Application details  Application country=AU AU2013269663  Application date=2013-05-29  Standardized application number=2013AU-0269663     Event publication date=2014-12-04  Event code=AU/A1  Event indicator=Pos  Event type=Examination events  Open to public inspection  Publication country=AU  Publication number=AU2013269663  Publication stage Code=A1  Publication date=2014-12-04  Standardized publication number=AU2013269663     Event publication date=2016-12-01  Event code=AU/B2  Event indicator=Pos  Event type=Event indicating In Force  Patent proceeded by OPI  Publication country=AU  Publication number=AU2013269663  Publication stage Code=B2  Publication date=2016-12-01  Standardized publication number=AU2013269663     Event publication date=2017-03-30  Event code=AU/FGA  Event indicator=Pos  Event type=Event indicating In Force  Letters patent sealed or granted (standard patent)
专利类型码
A1B2
国别省市代码
若您需要申请原文,请登录。

最新评论

暂无评论。

登录后可以发表评论

意见反馈
返回顶部